Page last updated: 2024-09-04

levofloxacin and Febrile Neutropenia

levofloxacin has been researched along with Febrile Neutropenia in 17 studies

Research

Studies (17)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's12 (70.59)24.3611
2020's5 (29.41)2.80

Authors

AuthorsStudies
Anjum, S; Raza, A; Rehman, P; Saeed, H; Shaukat, Z; Wali, RM1
Belsham, E; Bowcock, S; Campbell, G; Dawkins, B; Dignum, H; Drayson, MT; Dunn, JA; Hamblin, M; Harrison, B; Hawkey, P; Higgins, H; Hulme, CT; Iqbal, G; Karunanithi, K; Lokare, A; Low, E; Meads, D; Monahan, I; Neilson, J; Planche, T; Pratt, G; Raynes, K; Whittaker, AC; Wood, J; Yong, K1
Freifeld, A; Liewer, S; Shostrom, VK; Signorelli, J; Zimmer, A1
Harrison, SJ; Slavin, MA; Teh, BW; Thursky, KA; Worth, LJ1
Albrich, WC; Boggian, K1
Bello, L; Caneiro, A; Gai, R; Galeano, S; Miller, A; Mosquera, R; Muxi, P; Oliver, AC; Pierri, S; Riva, E1
Barreto, JN; Dierkhising, RA; Gangat, N; Mara, KC; Tosh, PK; Yemm, KE1
Bilker, W; Bink, K; Fitzpatrick, R; Gilmar, C; Gorman, T; Han, JH; Kraus, K; Kucharczuk, C; Landsburg, D; Mangan, P; Moore, A; Pegues, D; Stadtmauer, EA; Ziegler, M1
Chayakulkeeree, M; Owattanapanich, W1
Akashi, K; Aoki, T; Chong, Y; Ito, Y; Kamimura, T; Miyamoto, T; Shimoda, S; Shimono, N; Yakushiji, H1
Fujita, S; Hata, A; Kaji, R; Katakami, N; Kitajima, N; Masuda, Y; Ose, T; Takashima, K; Takeshita, J; Tanaka, K1
He, L; Weng, H; Yang, G; Zhao, S; Zhou, C1
Kurokawa, M; Nakamura, F; Nannya, Y; Shinohara, A; Taoka, K; Uni, M; Yamazaki, S; Yoshimi, A1
Gergis, U; Jacobs, SE; Mark, TM; Satlin, MJ; Shore, TB; Soave, R; Vardhana, S; Walsh, TJ1
Corrigan, PA; Hawks, KG; Kroll, AL; Patel, S1
Abbassi, M; Elborai, Y; Elhaddad, A; Hafez, HA; Yousif, D1
Inagaki, M; Kashiwaba, M; Kudo, K; Nihei, S; Sato, J1

Reviews

2 review(s) available for levofloxacin and Febrile Neutropenia

ArticleYear
Efficacy of levofloxacin as an antibacterial prophylaxis for acute leukemia patients receiving intensive chemotherapy: a systematic review and meta-analysis.
    Hematology (Amsterdam, Netherlands), 2019, Volume: 24, Issue:1

    Topics: Acute Disease; Bacteremia; Febrile Neutropenia; Female; Humans; Leukemia; Levofloxacin; Male

2019
Evaluation of empiric antibiotic de-escalation in febrile neutropenia.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2016, Volume: 22, Issue:5

    Topics: Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Febrile Neutropenia; Female; Humans; Leukocyte Count; Levofloxacin; Male; Middle Aged; Retrospective Studies

2016

Trials

2 trial(s) available for levofloxacin and Febrile Neutropenia

ArticleYear
Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial.
    The Lancet. Oncology, 2019, Volume: 20, Issue:12

    Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Double-Blind Method; Febrile Neutropenia; Female; Follow-Up Studies; Humans; Infections; Levofloxacin; Male; Middle Aged; Multiple Myeloma; Prognosis; Prospective Studies

2019
Once-daily, oral levofloxacin monotherapy for low-risk neutropenic fever in cancer patients: a pilot study in China.
    Anti-cancer drugs, 2015, Volume: 26, Issue:3

    Topics: Administration, Oral; Anti-Bacterial Agents; Asian People; Blood Cell Count; Febrile Neutropenia; Humans; Levofloxacin; Neoplasms; Pilot Projects; Treatment Outcome

2015

Other Studies

13 other study(ies) available for levofloxacin and Febrile Neutropenia

ArticleYear
Prophylactic Use Of Levofloxacin During Induction Of Acute Lymphoblastic Leukaemia In Children-Experience From Pakistan.
    JPMA. The Journal of the Pakistan Medical Association, 2023, Volume: 73, Issue:10

    Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Case-Control Studies; Child; Febrile Neutropenia; Humans; Levofloxacin; Pakistan; Precursor Cell Lymphoblastic Leukemia-Lymphoma

2023
Incidence of Febrile Neutropenia in Autologous Hematopoietic Stem Cell Transplant (HSCT) Recipients on levofloxacin prophylaxis.
    Transplant infectious disease : an official journal of the Transplantation Society, 2020, Volume: 22, Issue:2

    Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Clostridium Infections; Febrile Neutropenia; Female; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Levofloxacin; Male; Middle Aged; Retrospective Studies; Transplant Recipients; Transplantation, Autologous; Transplantation, Homologous

2020
Levofloxacin prophylaxis in patients with myeloma.
    The Lancet. Oncology, 2020, Volume: 21, Issue:2

    Topics: Antibiotic Prophylaxis; Double-Blind Method; Febrile Neutropenia; Humans; Levofloxacin; Multiple Myeloma

2020
Levofloxacin prophylaxis in patients with myeloma.
    The Lancet. Oncology, 2020, Volume: 21, Issue:2

    Topics: Antibiotic Prophylaxis; Double-Blind Method; Febrile Neutropenia; Humans; Levofloxacin; Multiple Myeloma

2020
Comparison of two different anti-infectious approaches after high-dose chemotherapy and autologous stem cell transplantation for hematologic malignancies in a 12-year period in British Hospital, Uruguay.
    Annals of hematology, 2020, Volume: 99, Issue:4

    Topics: Adolescent; Adult; Aged; Amikacin; Antibiotic Prophylaxis; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Ceftazidime; Ciprofloxacin; Febrile Neutropenia; Female; Fever of Unknown Origin; Hematologic Neoplasms; Humans; Incidence; Levofloxacin; Male; Meropenem; Middle Aged; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Transplantation, Autologous; Uruguay; Young Adult

2020
A comparison of levofloxacin and oral third-generation cephalosporins as antibacterial prophylaxis in acute leukaemia patients during chemotherapy-induced neutropenia.
    The Journal of antimicrobial chemotherapy, 2018, Jan-01, Volume: 73, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antineoplastic Agents; Bacteremia; Cephalosporins; Febrile Neutropenia; Female; Hematologic Neoplasms; Humans; Leukemia; Levofloxacin; Male; Middle Aged; Retrospective Studies; Young Adult

2018
Fluoroquinolone Prophylaxis Is Highly Effective for the Prevention of Central Line-Associated Bloodstream Infections in Autologous Stem Cell Transplant Patients.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2019, Volume: 25, Issue:5

    Topics: Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Clostridium Infections; Febrile Neutropenia; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Infection Control; Infections; Levofloxacin; Male; Middle Aged; Sepsis; Transplantation, Autologous

2019
Clinical impact of fluoroquinolone-resistant Escherichia coli in the fecal flora of hematological patients with neutropenia and levofloxacin prophylaxis.
    PloS one, 2014, Volume: 9, Issue:1

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Febrile Neutropenia; Feces; Female; Hematologic Neoplasms; Host-Pathogen Interactions; Humans; Levofloxacin; Male; Middle Aged; Prospective Studies; Treatment Outcome

2014
[Comparison of garenoxacin and levofloxacin for the prophylaxis of febrile neutropenia].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2014, Volume: 41, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Febrile Neutropenia; Female; Fluoroquinolones; Humans; Levofloxacin; Male; Middle Aged; Neoplasms; Retrospective Studies

2014
Comparison of garenoxacin with levofloxacin as antimicrobial prophylaxis in acute myeloid leukemia.
    Japanese journal of clinical oncology, 2015, Volume: 45, Issue:8

    Topics: Adult; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Bacterial Infections; Febrile Neutropenia; Female; Fluoroquinolones; Humans; Leukemia, Myeloid, Acute; Levofloxacin; Male; Middle Aged; Primary Prevention; Retrospective Studies; Sample Size

2015
Impact of Prophylactic Levofloxacin on Rates of Bloodstream Infection and Fever in Neutropenic Patients with Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2015, Volume: 21, Issue:10

    Topics: Antibiotic Prophylaxis; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Clostridioides difficile; Clostridium Infections; Combined Modality Therapy; Drug Resistance, Microbial; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Febrile Neutropenia; Female; Filgrastim; Guideline Adherence; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Incidence; Levofloxacin; Lymphoma; Male; Melphalan; Middle Aged; Multiple Myeloma; Practice Guidelines as Topic; Retrospective Studies; Risk Factors; Transplantation Conditioning; Transplantation, Autologous

2015
Prophylactic levofloxacin in pediatric neutropenic patients during autologous hematopoietic stem cell transplantation.
    Clinical transplantation, 2015, Volume: 29, Issue:12

    Topics: Adolescent; Antibiotic Prophylaxis; Bacteremia; Child; Child, Preschool; Febrile Neutropenia; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Hematopoietic Stem Cell Transplantation; Humans; Infant; Levofloxacin; Male; Prognosis; Risk Factors; Transplantation, Autologous

2015
[Efficacy of Levofloxacin Hydrate in Febrile Neutropenia for Outpatient Chemotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2016, Volume: 43, Issue:5

    Topics: Anti-Bacterial Agents; Antineoplastic Agents; Breast Neoplasms; Febrile Neutropenia; Humans; Levofloxacin; Middle Aged; Retrospective Studies

2016